Purchase Order 75N92025P00321

Award Date 8/16/25
Potential Completion Date 8/15/26
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,573.60 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The contract is for maintenance services on Qiagen's QIASYMPHONY SP 34311 equipment used to isolate cell-free DNA from lung transplant patient plasma samples. The contract period of performance is from August 1, 2025 to July 31, 2026. There is no...
This is a $13,858 firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. The contract is for the maintenance of QIAGEN laboratory equipment. It does not have a set-aside designation and has an ultimate completion date of May 14, 2028. Qiagen is a...
This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
This is a $33,368.50 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract is for the provision of DNA isolation kits from November 1, 2024 to September 30, 2025. The award is not associated with a set-aside program. Qiagen has a history of providing a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare...
This is a $10,768 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the provision of Qiagen's clinical insight analysis products and services, with a period of performance through September 28, 2026. Qiagen, a foreign-owned, for-profit manufacturer, specializes in molecular diagnostics, scientific equipment, and bioinformatics solutions. The...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and genomic analysis products. The $389,994.64 contract, which does not have a set-aside designation, is for the delivery of various scientific equipment and consumables to support NIEHS's biomedical research and public health initiatives. Key items included under the contract are DNA/RNA...
This is a federal contract award (75N90025P00400) issued by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic and life sciences products. The contract, valued at $30,071.70, is for a 12-month period of performance and includes the provision of Qiagen's QIAGILITY and QIASYMPHONY SP instruments and associated maintenance services. The contract is not associated with a set-aside program. Qiagen has previously been...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The $111,768.00 contract does not have a set-aside designation. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, is delivering products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen holds several...
This is a $24,978.80 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, part of the Department of Health and Human Services, to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic products. The contract requires Qiagen to provide QIAsymphony DSP circulating DNA kits to isolate cell-free DNA from plasma samples from lung transplant patients. This is likely in support of the agency's biomedical research and public health programs. The...

This is a $12,060 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is for maintenance services on Qiagen's EZ2 Connect and QIAcuity One instruments used for isolation and analysis of cell-free DNA. The contract has an ultimate completion date of August 15, 2026. Qiagen has established itself as a critical supplier of advanced scientific technologies to numerous federal agencies, providing a range of products and services including DNA/RNA extraction kits, sequencing equipment, and bioinformatics solutions. This contract award is not associated with any set-aside designation.

Generated 8/21/25, 9:54 AM